drugset / Trial / NCT02199327
Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
Phase 4
Completed
18 enrolled
Coordinación de Investigación en Salud, Mexico
Instituto Mexicano del Seguro Social · collabUniversity of Guadalajara · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the therapeutic efficacy of interferon alfa 2b and topical mitomycin C in patients with diagnosis of conjunctival-corneal intraepithelial neoplasia.
Timeline
- Start
- 2014-05
- Primary completion
- 2016-12-16
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mitomycin C | Other / unclassified | 0.04 % | Topical |
| Comparator | interferon alfa-2b | Protein / enzyme biologic | 1e+06 unknown | Topical |